Skip to main content
Clinical Trials/NCT01544075
NCT01544075
Unknown
Early Phase 1

Efficacy of Pain Neurophysiology Education in Combination With Psychologic Inoculation in Chronic Whiplash Associated Disorders : a Double-blind Randomised Controlled Trial

Vrije Universiteit Brussel1 site in 1 country36 target enrollmentFebruary 2012

Overview

Phase
Early Phase 1
Intervention
Not specified
Conditions
Pain, Chronic
Sponsor
Vrije Universiteit Brussel
Enrollment
36
Locations
1
Primary Endpoint
Change in pain pressure thresholds (conditioned pain modulation)
Last Updated
10 years ago

Overview

Brief Summary

With the present study the investigators wish to examine if reconceptualisation of pain, by educating chronic whiplash-associated disorders (CWAD) patients on the neurophysiology of pain, in combination with psychologic innoculation is able to influence maladaptive (pain) cognitions, pain (inhibition) and movement performance, and reduce symptoms.

Detailed Description

Results from a previous pilot study conducted by the same investigators suggest that intensive pain neurophysiology education (PNE) is able to increase pain thresholds and improve pain behavior and pain-free movement performance in patients with CWAD. However these results have not been confirmed in a randomized controlled trial. In addition, it has been emphasized that PNE is not a standalone treatment and that future research should examine PNE in combination with other treatment modalities. Another treatment modality that challenges people's beliefs and barriers is psychological inoculation (PI). However, it has not yet been examined if PI could be a useful component in the rehabilitation of chronic pain patients.

Registry
clinicaltrials.gov
Start Date
February 2012
End Date
September 2015
Last Updated
10 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Jessica Van Oosterwijck

Dr.

Vrije Universiteit Brussel

Eligibility Criteria

Inclusion Criteria

  • WAD grades I to II according to the Quebec Task Force criteria
  • with chronic pain as result of a whiplash injury
  • 18-65 years of age and with Dutch as their native language will be able to participate

Exclusion Criteria

  • other comorbidities or health issues that could explain the pain complaints
  • \< 18years \> 65 years

Outcomes

Primary Outcomes

Change in pain pressure thresholds (conditioned pain modulation)

Time Frame: Measured prior to (baseline=day 1) and immediate following (=day 13) the treatment. Long term changes examined at 3 months follow-up.

Measures over different locations on the body. Used as test stimulus while a conditioning stimulus is applied (conditioned pain modulation).

Secondary Outcomes

  • Change in scores on the Neck Disability Index questionnaire(Measured prior to (baseline=day 1) and immediate following (=day 13) the treatment. Long term changes examined at 3 months follow-up.)
  • Changes in scores on the Tampa Scale Kinesiophobia Questionnaire(Measured prior to (baseline=day 1) and immediate following (=day 13) the treatment. Long term changes examined at 3 months follow-up)
  • Changes in the Chronic Pain Self Efficacy Questionnaire(Measured prior to (baseline=day 1) and immediate following (=day 13) the treatment. Long term changes examined at 3 months follow-up.)
  • Changes in the scores on the Whiplash Associated Disorders Symptom list(Measured prior to (baseline=day 1) and immediate following (=day 13) the treatment. Long term changes examined at 3 months follow-up.)
  • Changes in scores on the Short Form 36 questionnaire(Measured prior to (baseline=day 1) and immediate following (=day 13) the treatment. Long term changes examined at 3 months follow-up.)
  • Changes in range of movement and pain during the Brachial Plexus Provocation Test(Measured prior to (baseline=day 1) and immediate following (=day 13) the treatment. Long term changes examined at 3 months follow-up.)
  • Hospital Anxiety and Depression Scale(Baseline=day1)
  • Changes in score on the Pain Coping Inventory Questionnaire(Measured prior to (baseline=day 1) and immediate following (=day 13) the treatment. Long term changes examined at 3 months follow-up.)
  • Changes is force during the Cranio Cervical Flexion Test(Measured prior to (baseline=day 1) and immediate following (=day 13) the treatment. Long term changes examined at 3 months follow-up.)
  • Changes in the scores on the Neurophysiology of Pain Test Questionnaire(Measured prior to (baseline=day 1) and immediate following (=day 13) the treatment. Long term changes examined at 3 months follow-up.)
  • Changes in pain during the Neck Extension Test(Measured prior to (baseline=day 1) and immediate following (=day 13) the treatment. Long term changes examined at 3 months follow-up.)
  • Changes in scores on the Pain Catastrophizing Scale Questionnaire(Measured prior to (baseline=day 1) and immediate following (=day 13) the treatment. Long term changes examined at 3 months follow-up.)
  • Impact of Events Scale(Baseline=day 1)

Study Sites (1)

Loading locations...

Similar Trials